The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis

Yu Zhang1,2,3, Jia Liu1,3, Dandan Yu1,3

  • 1School of Life Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Pudong, Shanghai, 201210, China.

Cell Death & Disease
|June 23, 2021
PubMed

Insights

Necroptosis execution involves mixed lineage kinase domain-like (MLKL) protein activation. This study reveals MLKL activation sequentially begins with kinase-like domain dimerization, followed by coiled-coil self-assembly for oligomerization and cell death.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • Necroptosis is a regulated form of necrosis crucial in inflammation and immunity.
  • Mixed lineage kinase domain-like (MLKL) protein activation, triggered by RIP3-mediated phosphorylation, is essential for necroptosis execution.
  • MLKL activation involves a transition from monomeric to oligomeric forms, but the precise steps remain incompletely understood.

Purpose of the Study:

  • To elucidate the sequential molecular events governing MLKL activation during necroptosis.
  • To investigate the role of MLKL kinase-like domain dimerization and coiled-coil self-assembly in MLKL oligomerization and function.
  • To determine if MLKL kinase-like domain dimerization is conserved across mammalian species.

Main Methods:

  • X-ray crystallography to determine the structure of human MLKL.
  • Site-directed mutagenesis to disrupt identified MLKL interfaces and coiled-coil regions.
  • Functional assays to assess MLKL oligomerization and necroptosis in response to RIP3 activation.

Main Results:

  • The crystal structure of human MLKL revealed two inter-dimer interfaces within the kinase-like domain.
  • Mutations disrupting both inter-dimer interfaces abolished RIP3-induced MLKL oligomerization and necroptosis.
  • MLKL self-assembly via its internal coiled-coil region was necessary for oligomerization and necroptosis, but not for initial kinase-like domain dimerization.
  • Kinase-like domain dimerization was conserved in MLKL from other mammalian species.

Conclusions:

  • MLKL activation is a sequential process initiated by RIP3-induced kinase-like domain dimerization.
  • Subsequent self-assembly of the internal coiled-coil region leads to the formation of functional MLKL oligomers.
  • This sequential activation mechanism, starting with kinase-like domain dimerization, is conserved in mammals, highlighting its fundamental role in necroptosis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.6K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
81.6K